Debas HT, Gosselin R, McCord C, Thind A Surgery. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, eds. Disease Control Priorities in Developing Countries. 2nd ed. Disease Control Priorities Project. Washington, DC: International Bank for Reconstruction and Development/World Bank 2006:1245-1260.
Gosselin RA, Maldonado A, Elder G Comparative cost-effectiveness analysis of two MSF surgical trauma centers. World J Surg. 2010 Mar;34(3):415-9. doi: 10.1007/s00268-009-0230-0.
Mainthia R, Tye GW, Shapiro J, Doppenberg EM, Ward JD A model for neurosurgical humanitarian aid based on 12 years of medical trips to South and Central America. J Neurosurg Pediatr. 2009 Jul;4(1):4-9. doi: 10.3171/2009.1.PEDS08193.
Maki J, Qualls M, White B, Kleefield S, Crone R Health impact assessment and short-term medical missions: a methods study to evaluate quality of care. BMC Health Serv Res. 2008 Jun 2;8:121. doi: 10.1186/1472-6963-8-121.
Martiniuk AL, Manouchehrian M, Negin JA, Zwi AB Brain Gains: a literature review of medical missions to low and middle-income countries. BMC Health Serv Res. 2012 May 29;12:134. doi: 10.1186/1472-6963-12-134. Review.
Moon W, Perry H, Baek RM Is international volunteer surgery for cleft lip and cleft palate a cost-effective and justifiable intervention? A case study from East Asia. World J Surg. 2012 Dec;36(12):2819-30. doi: 10.1007/s00268-012-1761-3.
Ozgediz D, Jamison D, Cherian M, McQueen K The burden of surgical conditions and access to surgical care in low- and middle-income countries. Bull World Health Organ. 2008 Aug;86(8):646-7.
Perkins RS, Casey KM, McQueen KA Addressing the global burden of surgical disease: proceedings from the 2nd annual symposium at the American College of Surgeons. World J Surg. 2010 Mar;34(3):371-3. doi: 10.1007/s00268-009-0338-2.
Pezzella AT Volunteerism and humanitarian efforts in surgery. Curr Probl Surg. 2006 Dec;43(12):848-929. Review.
Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, Murray CJ Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2144-62. doi: 10.1016/S0140-6736(12)61690-0. Erratum in: Lancet. 2013 Feb 23;381(9867):628.
Shillcutt SD, Clarke MG, Kingsnorth AN Cost-effectiveness of groin hernia surgery in the Western Region of Ghana. Arch Surg. 2010 Oct;145(10):954-61. doi: 10.1001/archsurg.2010.208.
Taira BR, Kelly McQueen KA, Burkle FM Jr Burden of surgical disease: does the literature reflect the scope of the international crisis? World J Surg. 2009 May;33(5):893-8. doi: 10.1007/s00268-009-9981-x. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.